285 related articles for article (PubMed ID: 30144822)
21. A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.
Padayachee S; Moodley J; Naicker T
Curr Hypertens Rep; 2019 Jul; 21(9):69. PubMed ID: 31342170
[TBL] [Abstract][Full Text] [Related]
22. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
23. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
24. Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia?
Kwiatkowski S; Dołęgowska B; Kwiatkowska E; Rzepka R; Marczuk N; Loj B; Mikolajek-Bedner W; Torbe A
J Matern Fetal Neonatal Med; 2019 Jan; 32(1):11-20. PubMed ID: 28816071
[TBL] [Abstract][Full Text] [Related]
25. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
26. Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.
Makris A; Yeung KR; Lim SM; Sunderland N; Heffernan S; Thompson JF; Iliopoulos J; Killingsworth MC; Yong J; Xu B; Ogle RF; Thadhani R; Karumanchi SA; Hennessy A
Hypertension; 2016 Jun; 67(6):1263-72. PubMed ID: 27091894
[TBL] [Abstract][Full Text] [Related]
27. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.
Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S
Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705
[TBL] [Abstract][Full Text] [Related]
28. Placental growth factor and pre-eclampsia.
Chau K; Hennessy A; Makris A
J Hum Hypertens; 2017 Dec; 31(12):782-786. PubMed ID: 29115294
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.
Suzuki H; Ohkuchi A; Matsubara S; Takei Y; Murakami M; Shibuya M; Suzuki M; Sato Y
Hypertension; 2009 Nov; 54(5):1129-35. PubMed ID: 19786649
[TBL] [Abstract][Full Text] [Related]
30. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
31. Placental growth factor in the cerebrospinal fluid of women with preeclampsia.
Foyouzi N; Norwitz ER; Tsen LC; Buhimschi CS; Buhimschi IA
Int J Gynaecol Obstet; 2006 Jan; 92(1):32-7. PubMed ID: 16242694
[TBL] [Abstract][Full Text] [Related]
32. Using the angiogenic factors sFlt-1 and PlGF with Doppler ultrasound of the uterine artery for confirming preeclampsia.
Bahlmann F; Al Naimi A
Arch Gynecol Obstet; 2016 Nov; 294(6):1133-1139. PubMed ID: 27256338
[TBL] [Abstract][Full Text] [Related]
33. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
[TBL] [Abstract][Full Text] [Related]
35. The perinatal implications of angiogenic factors.
Smith GC; Wear H
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):111-6. PubMed ID: 19996864
[TBL] [Abstract][Full Text] [Related]
36. [Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia].
Bubeníková Š; Cíchová A; Roubalová L; Durdová V; Vlk R
Ceska Gynekol; 2016; 81(4):272-278. PubMed ID: 27882748
[TBL] [Abstract][Full Text] [Related]
37. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
Moe K; Heidecke H; Dechend R; Staff AC
Pregnancy Hypertens; 2017 Oct; 10():83-89. PubMed ID: 29153696
[TBL] [Abstract][Full Text] [Related]
39. Angiogenic Imbalance as a Contributor of Preeclampsia.
Dymara-Konopka W; Laskowska M; Błażewicz A
Curr Pharm Biotechnol; 2018; 19(10):797-815. PubMed ID: 30255753
[TBL] [Abstract][Full Text] [Related]
40. Drug Repositioning for Preeclampsia Therapeutics by In Vitro Screening: Phosphodiesterase-5 Inhibitor Vardenafil Restores Endothelial Dysfunction via Induction of Placental Growth Factor.
Kakigano A; Tomimatsu T; Mimura K; Kanayama T; Fujita S; Minato K; Kumasawa K; Taniguchi Y; Kanagawa T; Endo M; Ishihara T; Namba T; Mizushima T; Kimura T
Reprod Sci; 2015 Oct; 22(10):1272-80. PubMed ID: 25736325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
